Rogel Cancer Center awarded $33.4M from NCI

5-year support grant also renews center’s ‘comprehensive’ status

Author | Nicole Fawcett

The National Cancer Institute has awarded the University of Michigan Rogel Cancer Center a grant worth $33.4 million over five years. At the same time, the center’s designation as a “comprehensive cancer center” was renewed.

The grant is a renewal of the Rogel Cancer Center’s support grant, provided as part of the NCI’s cancer centers program. U-M is in its 30th year of NCI funding for its cancer center. The new grant will fund the center through 2023. It represents a 9 percent increase over the previous support grant.

“This grant award reflects the tremendous breadth and depth of resources we have here at the University of Michigan. Rogel Cancer Center members take advantage of unique collaborations in top-ranked schools and colleges, engaging disciplines not typically thought to be central to attacking the cancer problem,” says Eric R. Fearon, M.D., Ph.D., Emanuel N. Maisel Professor of Oncology and director of the University of Michigan Rogel Cancer Center.

The Rogel Cancer Center submitted a 2,109-page grant renewal to the NCI in May 2017 and underwent a rigorous full-day site visit by reviewers in the fall. Overall, the center received an “outstanding” rating.

The grant supports seven research programs in basic science, clinical and translational research, and population sciences. It also provides funding for 13 shared resources, clinical trials oversight, educational programs and community outreach efforts.

Reviewers cited the center’s major strengths in applying genetics and genomics into clinical practice, calling the Rogel Cancer Center a national leader in tumor gene sequencing. It also cited major strengths in hematopoiesis, immunology and understanding the signaling pathways involved in cancer. Additional achievements were noted in cancer epidemiology, prevention, and health behavior and outcomes research.

“Under Dr. Fearon’s direction and expertise, the (Rogel Cancer Center) is expected to further enhance its translational capabilities into the clinic and to the populations in its catchment area. This application is of high impact due to the strong depth and breadth of science across basic, clinical and population-based cancer research,” the reviewers note.

To earn the designation of “comprehensive cancer center,” an institution must participate in basic, clinical, and prevention and control research, with strong interactions among those areas. A center must also provide public information, education and outreach programs. The Rogel Cancer Center is one of two comprehensive cancer centers in Michigan and one of 49 across the country.

Fearon was named director of the Rogel Cancer Center in 2016. He led a transformational reorganization of the center’s leadership, who worked together to develop a new strategic plan for the organization. In March 2018, Richard and Susan Rogel committed $150 million to the newly named Rogel Cancer Center.

Funding: National Cancer Institute grant P30CA046592

About the Rogel Cancer Center

The University of Michigan Rogel Cancer Center is committed to improving the health and well-being of people who have – or are at risk of getting – cancer. As a National Cancer Institute-designated comprehensive cancer center, our more than 500 members work to prevent cancer, improve outcomes for those diagnosed, and improve quality of life for cancer patients and survivors. Our 17 multidisciplinary cancer clinics offer one-stop access to teams of specialists who develop personalized treatment plans for each patient. Learn more at www.rogelcancercenter.org or call the U-M Cancer AnswerLine at 800-865-1125.

 

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories Woman poses with her family and after her college graduation
Health Lab
Clinical trial aims to treat HPV, cervical lesions without surgery
Patients can now enroll in a clinical trial to test a groundbreaking nonsurgical treatment for cervical lesions that affect nearly 300,000 women in the United States every year.
Health Lab
Positive outlook propels woman through heart failure and on to a new heart
After seven years of waiting, a Michigan woman celebrates a lifesaving heart transplant and recovery close to home
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Managing Chronic Pain for Patients with Long COVID
Therapies for pain conditions like fibromyalgia provide clues for helping those with long COVID.
Go Blue and Beyond
News Release
The wait is over: graduating medical students find out what’s next at Match Day
The wait is over: graduating medical students find out what’s next at Match Day
Enlargement of microscopic HIV virus cells
Health Lab
Researchers open new leads in anti-HIV drug development, using compound found in nature
Researchers open new leads in anti-HIV drug development, using a compound found in nature
Health Lab
Fitness instructor, backpacker returns to active lifestyle after years of pain from endometriosis
Woman seeks answers for painful periods, leading to the discovery of endometriosis, large ovarian cysts, organ inflammation and appendix cancer